Le Lézard
Classified in: Health
Subjects: SVY, PET

Veterinary CT Scanner Market Worth 173.7 Million USD by 2022


PUNE, India, August 17, 2017 /PRNewswire/ --

According to a new market research report "Veterinary CT Scanner Market by Type (Multi Slice CT Scanner, Portable CT Scanner), Animal (Small Animals, Equine, Livestock), Application (Neurology, Oncology, Orthopedic, Traumatology), End User (Animal Hospital, Clinic) - Global Forecast to 2022", published by MarketsandMarketstm, the Veterinary CT Scanner Market is expected to reach USD 173.7 Million by 2022 from an estimated USD 122.3 Million in 2017, at a CAGR of 7.3%.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 156 Market Data Tables and 28 Figures spread through 184 Pages and in-depth TOC on "Veterinary CT Scanner Market"

http://www.marketsandmarkets.com/Market-Reports/veterinary-ct-scanner-market-39631288.html

Early buyers will receive 10% customization on this report 

The key factors driving the growth of this market include the increasing small companion animal population, growing pet adoption, rising demand for pet insurance with growing animal health expenditure, growing number of veterinary practitioners and their income levels in developed economies, and innovation in veterinary CT scanners. However, the high cost of CT scanners may hinder the growth of this market to a certain extent. The steady growth in companion animal ownership in the emerging markets such as China, India, Brazil, and other Asia Pacific and Latin American countries serves as a significant growth opportunity for market players in the Veterinary CT Scanner Market.

By type, the stationary multi-slice CT scanners segment accounted for the largest share of the market in 2016

On the basis of type, the Veterinary CT Scanner Market is broadly segmented into stationary multi- slice CT scanners and portable CT scanners. In 2016, the stationary multi-slice CT scanners segment accounted for the largest share of this market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=39631288

This large share can be attributed to the higher adoption of multi-slice CT scanners, such as mid-end CT scanners and high-end CT scanners. Due to their lower prices (as compared to the high-end CT scanners), enhanced image quality and spatial imaging, increased scan speed, higher resolution, greater accuracy on on-the-spot diagnosis, and easy handling mid-end CT scanners are increasingly preferred over other CT scanners. The portable CT scanners segment is expected to grow at the highest CAGR during the forecast period.

By animal type, small companion animals accounted for the largest share of this market in 2016 

On the basis of animal type, the Veterinary CT Scanner Market is further segmented into small companion animals, equine and livestock, and other animals. In 2016, the small companion animals segment held the largest share of this market and is expected to grow at the highest CAGR during the forecast period. The growing population of small companion animals, rising pet ownership, increasing pet healthcare expenditure, and growing demand for pet insurance are the major factors driving the growth of this segment.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=39631288

By application, the neurology segment held the largest market share in 2016

Based on application, the market is segmented into neurology, oncology, orthopedics & traumatology, and other applications. The neurology segment accounted for the largest share and is expected to grow at the highest CAGR during the forecast period. The large share of this segment can mainly be attributed to the increasing prevalence of common brain disorders affecting the nervous system of animals, such as epilepsy, brain cancer/tumors, ischemic infarcts (stroke), encephalitis, hydrocephalus, and traumatic brain injuries.

North America dominated the market in 2016

North America accounted for the largest share of the Veterinary CT Scanner Market in 2016, followed by Europe and Asia Pacific. The largest share of this region is mainly attributed to the increasing adoption of pet animals, the growing pet insurance industry, and rising veterinary healthcare expenditure in the region.

The key players in the global Veterinary CT Scanner Market are GE Healthcare (US), Canon, Inc. (Toshiba Medical Systems Corporation) (Japan), Siemens AG (Siemens Healthineers) (Germany), Samsung Electronics Co. Ltd. (NeuroLogica Corporation) (South Korea), Epica Medical Innovation (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), Animage, LLC (US), GIN ApS (Denmark), QR s.r.l. (Italy), and 4DDI (US).

Browse Related Reports

VETERINARY IMAGING MARKET By Product (Ultrasound, Radiography, MRI, Video Endoscopy), Therapeutic Area (Oncology, Cardiology, Neurology, Orthopedic), Animal (Small Companion Animals, Large Animals), End User (Hospital, Clinic) - Global Forecast to 2022.

http://www.marketsandmarkets.com/Market-Reports/veterinary-imaging-market-80889726.html

SMALL ANIMAL IMAGING (IN-VIVO) MARKET by Modality (Optical Imaging, PET, SPECT, CT, MRI, ultrasound, Photoacoustic Imaging, Magnetic Particle Imaging), Reagent (Optical Imaging Reagents, Contrast Agents, PET Tracers, SPECT Probes) - Global forecast to 2021.

http://www.marketsandmarkets.com/Market-Reports/small-animal-imaging-market-957.html

About MarketsandMarketstm

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarketstm
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: +1-888-600-6441
Email: [email protected]

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: